Castuner

JACC Global

American College of Cardiology

Explore cardiovascular science from a global perspective with JACC Global. This podcast highlights original research, regional innovations, and urgent challenges in heart health across diverse healthcare settings worldwide.

Web del podcast

Escolta'l a la teva aplicació

Episodis

93 episodis

  1. ICI Myocarditis: Does Timing Define the Disease? | JACC Baran 34:25
  2. ICI Myocarditis: Does Timing Define the Disease? | JACC Baran 34:25
  3. Does PFA Reach the Vein of Marshall? | JACC Baran 36:20
  4. A SELUTION to Paclitaxel DCB Complications in PAD? | JACC Baran 28:08
  5. Proteomics in Action: Finding the Right Drug Targets for Ischemic Heart Disease | JACC Baran 35:48
  6. PET Unmasks CMD: The Hidden Risk Behind Normal Perfusion | JACC Baran 36:38
  7. Rethinking Health Care at Home and Abroad: Lancet RH Western Pacific Special | JACC Baran 39:47
  8. PFA Changes the Game and the AT Circuit | JACC Baran 36:55
  9. Is “Normal” Hemoglobin Really Normal in Heart Failure? | JACC Baran 33:28
  10. BRIDGING the Lipid Management Gap After ACS: ESC Late-Breaker | JACC Baran 43:20
  11. ESC 2026 Special: JACC SimPub Papers You Should Know | JACC Baran 36:26
  12. The Lancet: OPTIMA-AF, Is 1 Month Enough After PCI? | JACC Baran 47:48
  13. HFpEF: Why Earlier May Be Better | JACC Baran 38:20
  14. Post-PCI Hematoma: What IVUS Tells Us | JACC Baran 35:03
  15. Pediatric Heart Transplantation: When Priority Doesn't Match Urgency | JACC Baran 35:03
  16. PACs: Benign Bystanders or AF in Disguise? | JACC Baran 35:47
  17. Cancer VTE + DOAC: Who Will Bleed? | JACC Baran 39:48
  18. HFpEF Without Obesity: What Coronary Microcirculation Tells Us | JACC Baran 37:50
  19. What Autopsy Reveals About MINOCA and Sudden Cardiac Death | JACC Baran 45:32
  20. Remnant Cholesterol: Small Name, Big ASCVD Risk | JACC Baran 42:20
  21. Post-AF Ablation Anticoagulation: How Long Is Long Enough? | JACC Baran 44:30
  22. Ultra-Low-Dose CAC in the Photon-Counting Era | JACC Baran 33:14
  23. The Rise of PROs: What Traditional Risk Scores May Be Missing | JACC Baran 36:09
  24. After PCI, What Matters Most? Heart Failure, Bleeding, or Recurrent MI? | JACC Baran 35:42
  25. HFpEF and HFmrEF: Can KCCQ-12 Replace KCCQ-23? | JACC Baran 33:51
  26. Can AI Predict AF Recurrence After Cardioversion? | JACC Baran 32:32
  27. Mitral Stenosis: Beyond Rheumatic Disease | JACC Baran 31:20
  28. AF Ablation and the Brain: Does It Improve Blood Flow and Cognition? | JACC Baran 41:56
  29. Acute PE in Practice: An APAC View on the New AHA/ACC Guideline | JACC Baran 42:19
  30. Marfan Syndrome: Timing Surgery Through Genetics | JACC Baran 36:28
  31. Unraveling HCM Heterogeneity Using Circulating microRNAs | JACC Baran 27:47
  32. Chagas Cardiomyopathy — Epidemiology Through Modern Clinical Trials | JACC Baran 19:47
  33. Japanese Circulation Society 2026 Special — JACC at #26JCS | JACC Baran 21:02
  34. Mild PVR in TAVR — A Small Leak, Long-Term Impact | JACC Baran 36:18
  35. LDH in HFrEF — A Common Test, A Hidden Signal | JACC Baran 35:59
  36. TAVR and HFrEF — Are We Fully Applying GDMT? | JACC Baran 26:56
  37. TR and AFib After M-TEER: A Risk Interaction to Watch | JACC Baran 42:55
  38. HFpEF: Normal by Echo, Abnormal by Hemodynamics | JACC Baran 30:53
  39. Cardiac Sarcoidosis Beyond Suppression: Imaging and Biomarkers That Matter | JACC Baran 37:15
  40. Coronary Revascularization in the Real World: Evidence, Policy, and Practice in Japan | JACC Baran 32:17
  41. What Spontaneous Echo Contrast Reveals After Left Atrial Appendage Closure | JACC Baran 24:48
  42. Too Old for Ablation? Insights from AF Patients Aged 80 and Above | JACC Baran 34:24
  43. Japan’s Cardiovascular Playbook: A Living History Book of Prevention | JACC Baran 40:21
  44. M-TEER: Challenging the Status Quo With Outcome-Driven Metrics | JACC Baran 29:36
  45. PREVENT in East Asia: Can One Risk Score Fit All? | JACC Baran 37:15
  46. “Just One Drink?” Think Again — Blood Pressure Says Bye to Alcohol | JACC Baran 34:38
  47. CT-Based Plaque Norms: Rethinking Risk in Healthy Adults | JACC Baran 29:00
  48. Leave Nothing Behind: The Current and Future of Drug-Coated Balloons in PCI | JACC Baran 38:43
  49. A Global Look at Heart Disease: What the GBD Study Reveals | JACC Baran 31:09
  50. Ten Seconds That Matter: Clinical Frailty Scale in Heart Failure | JACC Baran 29:21